iShares Biotechnology ETF (IBB US) stock market data APIs

iShares Biotechnology ETF Financial Data Overview

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.

Get iShares Biotechnology ETF data using free add-ons & libraries

All libraries and code examples

---

MCP SK

All add-ons

End-of-day & Earnings data

iShares Biotechnology ETF News

New

Innovation Is Driving a New Bull Market in Biotech. 16 Ways to Play It, From Our Roundtable Experts.

2 days ago

Biotechnology stocks are soaring this year as medical advances and merger activity rekindle investor interest. More gains lie ahead, our healthcare panel says. Continue Reading

Moderna Adds Another 5% and Is Up 500% in 2026. Can MRNA Stock Continue the Melt-Up?

5 days ago

Quick Read MRNA has surged 506% in 2026 on a top-line win from the 1,137-patient INTerpath-001 melanoma trial, with full Phase 3 data due October 24. BNTX's 5% gain versus Moderna's 506% confirms the...

Moderna Surges 9% as Phase 3 Melanoma Data Wins Presidential Symposium Slot; Merck and BioNTech Edge Higher

6 days ago

Quick Read Moderna surged 9% to $168 after its Phase 3 melanoma vaccine study earned the ESMO congress's highest-profile Presidential Symposium slot on October 24. Merck gained just 1% and BioNTech 2...

Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher

1 week ago

Quick Read Moderna surged 5% to $152.83, extending a stunning 137% one-month run fueled solely by its Phase 2b melanoma vaccine data showing a 49% reduction in recurrence risk. BioNTech edged up just...

• Flexibility: No long-term commitments, just a minimum of one month
• Instant access: Get your API key and instructions within seconds of subscribing